Author details

Full Name

Roberto Bergamaschi

Affiliation

ORCID

Career Start Year

1986

Papers

279

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37542161	Prenatal exposure to environmental air pollution and psychosocial stress jointly contribute to the epigenetic regulation of the serotonin transporter gene in newborns.		2023
36441342	The economic impact of comorbidity in multiple sclerosis.	Neurological Sciences	2023
37582612	Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy: Two Case Reports and a Systematic Literature Review.		2023
37414534	Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.		2023
37405689	Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.		2023
36584654	Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study.		2023
36761349	Ultra-processed foods consumption is associated with multiple sclerosis severity.		2023
37068931	Disability accrual in primary and secondary progressive multiple sclerosis.		2023
36800908	Comparative effectiveness in multiple sclerosis: A methodological comparison.		2023
36692895	Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.		2023
37232279	Sars-CoV2 infection in pregnant women with multiple sclerosis.		2023
37515255	The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review.		2023
34749246	Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180].	Comput Methods Programs Biomed	2022
35971322	Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.	Multiple Sclerosis Journal	2022
35582938	Confirmed disability progression as a marker of permanent disability in multiple sclerosis.	European Journal of Neurology	2022
36288659	The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study.	Multiple Sclerosis and Related Disorders	2022
36092091	A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva PSP.	Frontiers in Psychology	2022
36086905	Signs and symptoms of COVID-19 in patients with multiple sclerosis.	European Journal of Neurology	2022
35500015	A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS).	PLoS ONE	2022
35810720	Bilateral coordination of gait at self-selected and fast speed in patients with multiple sclerosis: a case-control study.	Multiple Sclerosis and Related Disorders	2022
35373638	Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.	Mult Scler	2022
35420360	Cost-utility analysis of teriflunomide in naÃ¯ve vs. previously treated patients with relapsing-remitting multiple sclerosis in Italy.	Neurological Sciences	2022
36270254	Evidence for novel cell defense mechanisms sustained by dimethyl fumarate in multiple sclerosis patients: the HuR/SOD2 cascade.	Multiple Sclerosis and Related Disorders	2022
35675744	A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis.	Multiple Sclerosis and Related Disorders	2022
35672479	Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.	Neurol Sci	2022
35672479	Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.	Neurol Sci	2022
35410900	Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.	Neurology	2022
36479057	Barriers to exercise and the role of general practitioner: A cross-sectional survey among people with multiple sclerosis.		2022
34131815	Description and preliminary experience with Virtual Visit Assessment (ViVA) during the COVID-19 pandemic, a structured virtual management protocol for patients with multiple sclerosis.	Neurological Sciences	2022
34735749	The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.	European Journal of Neurology	2022
35216790	Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy.	Multiple Sclerosis and Related Disorders	2022
35029742	Disability and mortality in a cohort of MS patients: how the real-world scenario is changed.	Journal of Neurology	2022
35150168	Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis.	Annals of Neurology	2022
35325059	Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.	Brain	2022
34421801	Effects of Combined Endurance and Resistance Training in Women With Multiple Sclerosis: A Randomized Controlled Study.	Frontiers in Neurology	2021
32355992	The Dysphagia in Multiple Sclerosis Questionnaire Correlates with Fiber-Optic Endoscopic Examination for Detecting Swallowing Deficits in MS.	Dysphagia	2021
34104220	Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.	Therapeutic Advances in Neurological Disorders	2021
33616742	Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.	J Neurol	2021
33879599	Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.	Neurology	2021
34146771	Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression.	Comput Methods Programs Biomed	2021
33609958	Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients.	Multiple Sclerosis and Related Disorders	2021
33210986	Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.	Multiple Sclerosis Journal	2021
32538713	Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.	Multiple Sclerosis Journal	2021
33372028	Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.	Neurology	2021
32804349	Circulating endothelial progenitor cells during pregnancy in multiple sclerosis.	Neurological Sciences	2021
33024022	Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a.	Neurology	2021
32894443	PM exposure as a risk factor for multiple sclerosis. An ecological study with a Bayesian mapping approach.	Environmental Science and Pollution Research	2021
33423618	Determinants of therapeutic lag in multiple sclerosis.	Multiple Sclerosis Journal	2021
34868629	Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire).	Mult Scler J Exp Transl Clin	2021
34676793	Air pollution is a risk factor for multiple sclerosis - Yes.	Multiple Sclerosis Journal	2021